So far, few biomarkers have been well recognized in invasive breast carcinomas, including estrogen receptor (ER) and progesterone receptor (PR), which are associated with a better outcome and are predictive of endocrine sensitivity. Here, ESR1 is linked to invasive breast carcinoma.